Toru Umehara

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 103 citations

Neuro-oncology, Somatic Variant, Medicine +9

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts

Toru Umehara, Hideyuki Arita, Ema Yoshioka et al. · Acta Neuropathologica Communications · 2019 · 71 citations · Full text

Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms

Shuhei Kawabata, Masatoshi Takagaki, Hajime Nakamura et al. · Stroke · 2021 · 51 citations · Full text

Clinical significance of <i>CDKN2A</i> homozygous deletion in combination with methylated <i>MGMT</i> status for <i>IDH</i>‐wildtype glioblastoma

Yusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa et al. · Cancer Medicine · 2021 · 33 citations · Full text

11C-methionine-18F-FDG dual-PET-tracer–based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy

Takero Hirata, Manabu Kinoshita, Keisuke Tamari et al. · Journal of neurosurgery · 2018 · 23 citations